Cyrille B. Confavreux

Faculté De Médecine Lyon Est
Lyon, 69003, France

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 98 publications

Dissociated skeletal response to first-line immunotherapy in synchronous bone metastatic non-small cell lung cancer patients: Clinical profiles and survival benefit of denosumab adjunction.

Dissociated skeletal response to first-line immunotherapy in synchronous bone metastatic non-small cell lung cancer patients: Clinical profiles and survival benefit of denosumab adjunction.

Journal: Journal of bone oncology

Published: July 08, 2026

Patients with Cancer and Immune Checkpoint Inhibitor-Induced Rheumatic irAEs Treated by DMARDs: The RHUMICI Single-Centre Retrospective Cohort.

Patients with Cancer and Immune Checkpoint Inhibitor-Induced Rheumatic irAEs Treated by DMARDs: The RHUMICI Single-Centre Retrospective Cohort.

Journal: Cancers

Published: June 07, 2026

Predicting mechanical failure in spinal metastases: from clinical scores to patient-specific biomechanical modeling.

Predicting mechanical failure in spinal metastases: from clinical scores to patient-specific biomechanical modeling.

Journal: Neuro-Chirurgie

Published: April 21, 2026

Rituximab-induced hypogammaglobulinemia in autoimmune cytopenia and associated diseases.

Rituximab-induced hypogammaglobulinemia in autoimmune cytopenia and associated diseases.

Journal: La Revue de medecine interne

Published: April 08, 2026

Interventional radiology in bone metastases: current concepts and perspectives.

Interventional radiology in bone metastases: current concepts and perspectives.

Journal: Joint bone spine

Published: March 27, 2026

Real-life use of bone-targeting agents for bone metastases in France between 2009 and 2018: Results of the OPTIMOS study.

Real-life use of bone-targeting agents for bone metastases in France between 2009 and 2018: Results of the OPTIMOS study.

Journal: Journal of bone oncology

Published: December 12, 2025

Sensitivity analysis of a patient-specific finite element simulation pipeline incorporating automated vertebral segmentation for predicting vertebral strength of a clinical database.

Sensitivity analysis of a patient-specific finite element simulation pipeline incorporating automated vertebral segmentation for predicting vertebral strength of a clinical database.

Journal: Journal of the mechanical behavior of biomedical materials

Published: December 04, 2025

Clustering reveals diagnostic overlap between Still's disease and a hyperinflammatory subset of seronegative rheumatoid arthritis.

Clustering reveals diagnostic overlap between Still's disease and a hyperinflammatory subset of seronegative rheumatoid arthritis.

Journal: Scientific reports

Published: November 28, 2025

Unveiling sarcopenia prevalence in post-cancer patients: Integrating functional and morphological assessments for accurate diagnosis.

Unveiling sarcopenia prevalence in post-cancer patients: Integrating functional and morphological assessments for accurate diagnosis.

Journal: Joint bone spine

Published: July 28, 2025

Contribution of the immune bone marrow microenvironment to tumor growth and bone deconstruction: implications for improving immunotherapeutic strategies in bone metastasis.

Contribution of the immune bone marrow microenvironment to tumor growth and bone deconstruction: implications for improving immunotherapeutic strategies in bone metastasis.

Journal: Neoplasia (New York, N.Y.)

Published: July 28, 2025

Non-metastatic breast cancer patients discontinuing aromatase inhibitor on denosumab: what next?

Non-metastatic breast cancer patients discontinuing aromatase inhibitor on denosumab: what next?

Journal: Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA

Published: May 06, 2025

Management of aromatase inhibitor-associated bone loss (AIBL) in women with hormone-sensitive breast cancer: An updated joint position statement of the IOF, CABS, ECTS, IEG, ESCEO, IMS, and SIOG.

Management of aromatase inhibitor-associated bone loss (AIBL) in women with hormone-sensitive breast cancer: An updated joint position statement of the IOF, CABS, ECTS, IEG, ESCEO, IMS, and SIOG.

Journal: Journal of bone oncology

Published: April 09, 2025

Showing 1-12 of 98

Last Updated: 09/26/2026